Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 19, Number 2—February 2013

Dispatch

Human Granulocytic Anaplasmosis, Japan

Norio Ohashi1Comments to Author , Gaowa1, Wuritu, Fumihiko Kawamori, Dongxing Wu, Yuko Yoshikawa, Seizou Chiya, Kazutoshi Fukunaga, Toyohiko Funato, Masaaki Shiojiri2, Hideki Nakajima3, Yoshiji Hamauzu, Ai Takano, Hiroki Kawabata, Shuji Ando, and Toshio Kishimoto

Author affiliations: University of Shizuoka and Global Center of Excellence Program, Shizuoka City, Japan (N. Ohashi, Gaowa, Wuritu, F. Kawamori, D. Wu, Y. Yoshikawa); Kochi Institute of Health, Kochi City, Japan (S. Chiya, K. Fukunaga); Shizuoka Institute of Environment and Hygiene, Shizuoka City (F. Kawamori); Muroto Hospital, Muroto, Japan (T. Funato); Kochi Prefectural Aki Hospital, Aki City, Japan (M. Shiojiri, H. Nakajima); Chu-gei Clinic, Aki District, Japan (Y. Hamauzu); National Institute of Infectious Diseases, Tokyo, Japan (A. Takano, H. Kawabata, S. Ando); Okayama Prefectural Institute for Environmental Science and Public Health, Okayama, Japan (T. Kishimoto)

Main Article

Figure 2

Western blot analyses, using recombinant P44-1 protein (rP44-1) and Anaplasma phagocytophilum–infected THP-1 cells as antigens, of serum samples from 2 men, case-patients 1 and 2, who had A. phagocytophilum infection, Kochi Prefecture, Japan. The Escherichia coli, which produced rP44-1, was kindly provided by Yasuko Rikihisa (Ohio State University, Columbus, OH, USA). The rP44-1 and the rabbit hyperimmune serum (positive control serum) were prepared as described (11,12). Results for a negative c

Figure 2. . . Western blot analyses, using recombinant P44-1 protein (rP44-1) and Anaplasma phagocytophilum–infected THP-1 cells as antigens, of serum samples from 2 men, case-patients 1 and 2, who had A. phagocytophilum infection, Kochi Prefecture, Japan. The Escherichia coli, which produced rP44-1, was kindly provided by Yasuko Rikihisa (Ohio State University, Columbus, OH, USA). The rP44-1 and the rabbit hyperimmune serum (positive control serum) were prepared as described (11,12). Results for a negative control (human serum sample) are included. The primary human serum samples tested were diluted 200- to 400-fold; rabbit serum sample (positive control) was diluted 2,000-fold. The goat antihuman IgG and IgM alkaline phosphatase conjugates (Life Technologies, Grand Island, NY, USA) were used as secondary antibodies. Days represent days after symptom onset. rP, rP44-1 antigen; In, infected THP-1; Un, uninfected THP-1 cells.

Main Article

1These authors contributed equally to this article.

2Current affiliation: Ehime Prefectural Central Hospital, Matsuyama, Ehime, Japan.

3Current affiliation: Kochi Medical School, Nankoku, Kochi, Japan.

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO